THOR - Trauma Hemostasis & Oxygenation Research Network

06/09/2026

It is time to stop procrastinating and register for the State of the Science in Resuscitation Medicine for Severe Traumatic Bleeding that is being organized by THOR and CNS in Italy. Go to https://thorrome.com for more information and to sign up for what promises to be an informative and provocative review of optimal methods to assess and treat life threatening bleeding in both civilian and military scenarios. European regulatory topics regarding the availability of innovative blood products will also be thoroughly discussed.

Featured speakers:
Jennifer Gurney
Jason Sperry
Karim Brohi
Macky Neal
Andre Cap
Don Jenkins
Anirban SenGupta
Jeremy Cannon
Bryan Cotton
Kevin Ward
Mark Yazer
Holly O'Byrne
Allan Doctor
Phil Spinella

21/07/2026

The most comprehensive course on the market. Send your prehospital educators and providers to this course.

13/07/2026

Registration is open to all who want to attend. Please forward this post to anyone interested in learning about why and how to implement hemostatic resuscitation in both civilian systems and military medical units.

Improving outcomes for patients with severe traumatic bleeding requires collaboration across trauma care, transfusion medicine, emergency medicine, and critical care.

The THOR–CNS Rome 2026 Conference will bring together international leaders to share the latest research and system innovations in trauma resuscitation.

Key topics include:
• Prehospital transfusion strategies
• Civilian and military trauma integration
• Advances in blood products and hemostatic agents
• Regulatory developments in Substances of Human Origin (SoHO)

This conference is endorsed by leading scientific societies including SIMTI – Italian Society of Transfusion Medicine and Immunohematology.
📍 Rome, Italy
📅 November 10–11, 2026

Learn more:
https://thorrome.com

-CNS

07/07/2026

Happening today: THOR’s free educational webinar begins at 11:00 am EDT.

THOR Webinar Series: Blood Products as Pharmaceuticals

Join us for a Free Educational Webinar:

LIVE Virtual session
Tuesday July 7th, 11:00 am EDT
Blood Products as Pharmaceuticals: Should that be our Goal?
Presenter: Dr. Steve Spitalnik, MD
FREE and NO REGISTRATION required, just click and join!
thornetwork.com/webinar

This talk challenges the current paradigm of transfusion medicine by arguing that blood products should be treated as pharmaceuticals, with defined dosing, potency, and quality metrics rather than as variable biological units.

It highlights major gaps in current practice including imprecise “one-unit” dosing, reliance on limited outcomes like 30-day mortality, and variability driven by donor, product, and patient factors.

The presentation ultimately advocates for precision transfusion medicine, leveraging detailed characterization, predictive models, and individualized dosing to deliver the right blood product to the right patient at the right time.

06/07/2026

Improving outcomes for patients with severe traumatic bleeding requires collaboration across trauma care, transfusion medicine, emergency medicine, and critical care.

The THOR–CNS Rome 2026 Conference will bring together international leaders to share the latest research and system innovations in trauma resuscitation.

Key topics include:
• Prehospital transfusion strategies
• Civilian and military trauma integration
• Advances in blood products and hemostatic agents
• Regulatory developments in Substances of Human Origin (SoHO)

This conference is endorsed by leading scientific societies including SIMTI – Italian Society of Transfusion Medicine and Immunohematology.
📍 Rome, Italy
📅 November 10–11, 2026

Learn more:
https://thorrome.com

-CNS

03/07/2026

Reminder: THOR’s next free educational webinar is this Tuesday.

THOR Webinar Series: Blood Products as Pharmaceuticals

Join us for a Free Educational Webinar:

LIVE Virtual session
Tuesday July 7th, 11:00 am EDT
Blood Products as Pharmaceuticals: Should that be our Goal?
Presenter: Dr. Steve Spitalnik, MD
FREE and NO REGISTRATION required, just click and join!
thornetwork.com/webinar

This talk challenges the current paradigm of transfusion medicine by arguing that blood products should be treated as pharmaceuticals, with defined dosing, potency, and quality metrics rather than as variable biological units.

It highlights major gaps in current practice including imprecise “one-unit” dosing, reliance on limited outcomes like 30-day mortality, and variability driven by donor, product, and patient factors.

The presentation ultimately advocates for precision transfusion medicine, leveraging detailed characterization, predictive models, and individualized dosing to deliver the right blood product to the right patient at the right time.

01/07/2026

THOR Webinar Series: Blood Products as Pharmaceuticals

Join us for a Free Educational Webinar:

LIVE Virtual session

Tuesday July 7th,11:00 am EDT

Blood Products as Pharmaceuticals: Should that be our Goal?

Presenter: Dr. Steve Spitalnik, MD

FREE and NO REGISTRATION required - just click and join!

https://thornetwork.com/webinar

Description of Presentation

This talk challenges the current paradigm of transfusion medicine by arguing that blood products should be treated as pharmaceuticals, with defined dosing, potency, and quality metrics rather than as variable biological units.

It highlights major gaps in current practice including imprecise “one-unit” dosing, reliance on limited outcomes like 30-day mortality, and variability driven by donor, product, and patient factors, while drawing on clinical trials and emerging data to illustrate these limitations.

The presentation ultimately advocates for “precision transfusion medicine,” leveraging detailed characterization, predictive models, and individualized dosing to deliver the right blood product to the right patient at the right time.

24/06/2026

Registration is open for THOR–CNS Rome 2026!

This international conference will bring together leaders in trauma care, transfusion medicine, emergency medicine, and health system leadership to advance the science of resuscitation for severe traumatic bleeding.

📍 Rome, Italy
📅 November 10–11, 2026

Key themes include:
• Prehospital transfusion strategies
• Civilian and military trauma integration
• Advances in blood products and hemostatic agents
• European regulatory developments in Substances of Human Origin (SoHO)

Register and learn more:
🌐 https://thorrome.com

-CNS
Centro Nazionale Sangue

12/06/2026

Congrats to Audra Taylor and Bethany Weathersby for both winning the THOR impact award for their outstanding contributions that have changed practice and improved outcomes for thousands of people. Two amazing THOR warriors that continue to fight the good fight and make the world a better place.

09/06/2026

The afternoon scientific session at focused on the common biology of hemorrhagic shock and what it may take to move trauma care closer to precision medicine.

Dr. Karim Brohi opened with a discussion of the diagnostic and therapeutic gaps that still exist in hemorrhage care, including why trauma trials may miss important treatment effects when patients are studied as one broad group rather than by the endotypes most likely to benefit.

Dr. Andre Cap followed with a review of the shared biology underlying hemorrhagic shock and how lessons from different forms of shock and critical illness may help guide future therapies.

Dr. Afshin Beheshti closed the session by discussing how omics technologies and AI can help identify biologic targets and support more individualized resuscitation strategies.

The takeaway: the future of trauma care may depend less on finding one “magic bullet” and more on understanding which treatment is right for which patient.